Dexamethasone
Anti-inflammatory · Rx
RxAnti-inflammatorySteroid Pink cap
| Strength | 0.1% suspension; 0.4 mg intracanalicular insert |
|---|---|
| Typical quantity | 5 mL bottle (generic); Dextenza/Ozurdex are separate office-placed implants |
| Cash cost / month | Low · ~$0-20 |
| Drug class | Corticosteroid, fluorinated |
| Mechanism of action | Potent fluorinated glucocorticoid; broad suppression of inflammatory mediators. |
| Indication / reason for use | Steroid-responsive inflammatory conditions of the anterior segment; Dextenza for post-surgical inflammation/pain and allergic conjunctivitis itching. |
| Usual adult dosing | Maxidex 1-2 drops q1h initially, tapering to 4-6×/day; shake well. |
| Preservative | BAK |
| Contact lenses | Do not wear lenses during treatment. |
| Common / important adverse effects | IOP elevation, cataract, delayed healing, infection potentiation. |
| Contraindications & cautions | Active epithelial herpes simplex, fungal, mycobacterial infection. |
| Pregnancy / lactation | Limited data. |
| Trade names | Maxidex, Dextenza (insert), Ozurdex (intravitreal implant) |
| Practice notes | Dextenza avoids adherence problems by delivering a tapering dose over ~30 days from the canaliculus. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.